Baxter (BAX) – Reuters
-
Ozempic's early success in kidney disease trial drags down dialysis stocks
-
U.S. SEC announces charges, penalty on medtech firm Baxter for accounting improprieties
-
Big-name U.S. hedge funds shed healthcare stocks during the rally in second-quarter
-
Top U.S. hedge funds bet on Morgan Stanley and AIG
-
Shire, Baxalta to announce merger as soon as Monday: sources
-
Exclusive: Shire closer to deal to buy Baxalta - sources
-
Exclusive: Shire prepares to make new bid for Baxalta - source
-
Hedge funds Third Point, Jana Partners post losses in September
-
Shire seen having wiggle room on price in $30 billion Baxalta battle
Back to BAX Stock Lookup